HRP980196B1 - Novel 4-halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing the same - Google Patents
Novel 4-halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing the sameInfo
- Publication number
- HRP980196B1 HRP980196B1 HR980196A HRP980196A HRP980196B1 HR P980196 B1 HRP980196 B1 HR P980196B1 HR 980196 A HR980196 A HR 980196A HR P980196 A HRP980196 A HR P980196A HR P980196 B1 HRP980196 B1 HR P980196B1
- Authority
- HR
- Croatia
- Prior art keywords
- medicines
- intermediates
- novel
- preparation
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9704321A FR2761992B1 (fr) | 1997-04-09 | 1997-04-09 | Nouveaux steroides 4-halogenes, leur procede et intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP980196A2 HRP980196A2 (en) | 1998-12-31 |
HRP980196B1 true HRP980196B1 (en) | 2003-08-31 |
Family
ID=9505672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR980196A HRP980196B1 (en) | 1997-04-09 | 1998-04-08 | Novel 4-halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing the same |
Country Status (31)
Country | Link |
---|---|
US (5) | US6239121B1 (es) |
EP (1) | EP0973793B1 (es) |
JP (1) | JP4347420B2 (es) |
KR (1) | KR20010006149A (es) |
CN (1) | CN1259956A (es) |
AP (1) | AP1137A (es) |
AR (1) | AR012377A1 (es) |
AT (1) | ATE220408T1 (es) |
AU (1) | AU750030B2 (es) |
BR (1) | BR9809578A (es) |
CA (1) | CA2285679A1 (es) |
DE (1) | DE69806473T2 (es) |
DK (1) | DK0973793T3 (es) |
EA (1) | EA002116B1 (es) |
ES (1) | ES2178208T3 (es) |
FR (1) | FR2761992B1 (es) |
HR (1) | HRP980196B1 (es) |
HU (1) | HUP0002457A3 (es) |
ID (1) | ID22930A (es) |
IL (1) | IL132202A (es) |
NO (1) | NO315049B1 (es) |
NZ (1) | NZ337947A (es) |
PL (1) | PL190629B1 (es) |
PT (1) | PT973793E (es) |
SK (1) | SK284480B6 (es) |
TR (1) | TR199902507T2 (es) |
TW (1) | TW505621B (es) |
UA (1) | UA57073C2 (es) |
WO (1) | WO1998045316A1 (es) |
YU (1) | YU51199A (es) |
ZA (1) | ZA983046B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2757519B1 (fr) * | 1996-12-23 | 1999-06-11 | Hoechst Marion Roussel Inc | Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant |
FR2780060B1 (fr) | 1998-06-23 | 2000-08-04 | Hoechst Marion Roussel Inc | Nouveaux 19-nor steroides 17-halogenes, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant |
FR2826004B1 (fr) * | 2001-06-13 | 2008-03-28 | Aventis Pharma Sa | Procede de preparation de derives estrogenes |
FR2854402B1 (fr) * | 2003-04-29 | 2008-07-04 | Aventis Pharma Sa | Nouveau procede et intermediaires de preparation de composes 19-nor-steroides |
CN101589046B (zh) * | 2006-12-29 | 2011-09-21 | 弗·哈夫曼-拉罗切有限公司 | 氮杂螺环衍生物 |
WO2010085747A1 (en) * | 2009-01-23 | 2010-07-29 | Northeastern University | Steroidal anti-hormone hybrids |
FR2942409B1 (fr) * | 2009-02-20 | 2013-07-26 | Natacha Voillot | Composition pharmaceutique pour la prevention des avortements a repetition. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2640977A2 (en) * | 1982-06-11 | 1990-06-29 | Roussel Uclaf | New position-11 substituted 19-norsteroids and their application as medicinal products. |
US4676932A (en) * | 1984-04-09 | 1987-06-30 | The University Of New Mexico | Synthesis of 1-haloestradiols |
US4859585A (en) * | 1986-04-17 | 1989-08-22 | Trustees Of Tufts College | In-vitro methods for identifying compositions which are agonists and antagonists of estrogens |
-
1997
- 1997-04-09 FR FR9704321A patent/FR2761992B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-01 TW TW087104892A patent/TW505621B/zh not_active IP Right Cessation
- 1998-04-08 EA EA199900909A patent/EA002116B1/ru not_active IP Right Cessation
- 1998-04-08 ES ES98920587T patent/ES2178208T3/es not_active Expired - Lifetime
- 1998-04-08 YU YU51199A patent/YU51199A/sh unknown
- 1998-04-08 AU AU73396/98A patent/AU750030B2/en not_active Ceased
- 1998-04-08 KR KR1019997009228A patent/KR20010006149A/ko not_active Application Discontinuation
- 1998-04-08 AR ARP980101631A patent/AR012377A1/es active IP Right Grant
- 1998-04-08 DE DE69806473T patent/DE69806473T2/de not_active Expired - Lifetime
- 1998-04-08 DK DK98920587T patent/DK0973793T3/da active
- 1998-04-08 HR HR980196A patent/HRP980196B1/xx not_active IP Right Cessation
- 1998-04-08 IL IL13220298A patent/IL132202A/en active IP Right Grant
- 1998-04-08 AP APAP/P/1999/001656A patent/AP1137A/en active
- 1998-04-08 JP JP54246298A patent/JP4347420B2/ja not_active Expired - Fee Related
- 1998-04-08 EP EP98920587A patent/EP0973793B1/fr not_active Expired - Lifetime
- 1998-04-08 PT PT98920587T patent/PT973793E/pt unknown
- 1998-04-08 PL PL98336116A patent/PL190629B1/pl unknown
- 1998-04-08 US US09/402,705 patent/US6239121B1/en not_active Expired - Lifetime
- 1998-04-08 CA CA002285679A patent/CA2285679A1/fr not_active Abandoned
- 1998-04-08 AT AT98920587T patent/ATE220408T1/de not_active IP Right Cessation
- 1998-04-08 BR BR9809578-1A patent/BR9809578A/pt not_active IP Right Cessation
- 1998-04-08 NZ NZ337947A patent/NZ337947A/en unknown
- 1998-04-08 CN CN98805963A patent/CN1259956A/zh active Pending
- 1998-04-08 SK SK1362-99A patent/SK284480B6/sk unknown
- 1998-04-08 TR TR1999/02507T patent/TR199902507T2/xx unknown
- 1998-04-08 ID IDW991174A patent/ID22930A/id unknown
- 1998-04-08 WO PCT/FR1998/000709 patent/WO1998045316A1/fr not_active Application Discontinuation
- 1998-04-08 HU HU0002457A patent/HUP0002457A3/hu unknown
- 1998-04-09 ZA ZA983046A patent/ZA983046B/xx unknown
- 1998-08-04 UA UA99116107A patent/UA57073C2/uk unknown
-
1999
- 1999-10-08 NO NO19994908A patent/NO315049B1/no not_active IP Right Cessation
-
2000
- 2000-12-08 US US09/733,377 patent/US6472382B2/en not_active Expired - Lifetime
- 2000-12-22 US US09/746,245 patent/US6462211B1/en not_active Expired - Lifetime
-
2001
- 2001-01-10 US US09/757,679 patent/US6399766B2/en not_active Expired - Lifetime
- 2001-01-10 US US09/757,678 patent/US20010005756A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL135920A0 (en) | 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor | |
HUP0101155A3 (en) | Imidazonaphthyridines, pharmaceutical compositions thereof and intermediates | |
IL136938A0 (en) | 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
IL131415A (en) | Anti-inflammatory compounds, processes for their preparation and pharmaceutical compositions comprising them | |
HUP0102307A3 (en) | Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates | |
HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
PL345040A1 (en) | Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same | |
IL190215A0 (en) | Novel substituted imidazole compounds, their preparation and pharmaceutical compositions comprising them | |
HUP9700328A3 (en) | Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates | |
HUP0004024A3 (en) | Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof | |
IL115039A (en) | Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them | |
HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
AU2841199A (en) | Novel bis-benzamide derivatives, method for making same pharmaceutical compositions containing them and use thereof as medicine | |
HUP0001093A3 (en) | Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation | |
NZ291597A (en) | Carboxycyclopropan-1-yl derivatives, preparation, pharmaceutical compositions and intermediates thereof | |
HRP980196B1 (en) | Novel 4-halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing the same | |
ZA973289B (en) | Steroids, their use as medicaments, their preparation process, the intermediates of this process and the compositions containing them. | |
HU9603388D0 (en) | New taxoids, preparation thereof and pharmaceutical compositions containing them | |
IL112567A0 (en) | Substituted quinolines, their preparation and pharmaceutical compositions containing them | |
HUP0100210A3 (en) | Novel 11betha-substituted 19-nor steroids, preparation thereof, intermediates and pharmaceutical compositions containing them | |
HUP0003463A3 (en) | Piperidinylmethyloxazolidinone derivative, process for its preparation pharmaceutical compositions containing it and use thereof | |
IL112566A0 (en) | Substituted quinolinones, their preparation and pharmaceutical compositions containing them | |
SI0973793T1 (en) | Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same | |
PL345073A1 (en) | Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same | |
IL112568A0 (en) | Substituted quinolines, their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
PNAN | Change of the applicant name, address/residence |
Owner name: AVENTIS PHARMA S.A., FR |
|
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20040330 Year of fee payment: 7 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20050409 |